IMMUNOSCAPE PTE. LTD.
Country of registration | Singapore |
Registration number | 201633363C |
Local SIC | |
Incorporation date | 7 Dec 2016 |
Company age | 9 years 5 months |
Official entity type | Private Limited Company |
No. of officers | 57 |
Contact
1 SCOTTS ROAD, #24-10, SHAW CENTRE, Singapore 228208
This is the legal entity page of IMMUNOSCAPE PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- IMMUNOSCAPEView MoreSingaporeImmunoScape is a pre-clinical biotech company specializing in the discovery and development of cutting-edge TCR cell therapies for cancer treatment. Our proprietary Deep Immunomics technology allows for comprehensive analysis of T cells in cancer patient samples, enabling the identification of novel, therapeutically relevant TCRs across various solid tumor types. With multiple discovery programs underway, we are poised to enter the clinic and make a meaningful impact in the field of oncology.
Auditor | DELOITTE & TOUCHE LLP |
Revenue | > 10m |
Share Capital - Ordinary shares | SGD 529,716 |
Share Capital - Preference shares | USD 20,424,132 |
Share Capital - Preference shares | SGD 17,862,646 |
Frequently Asked Questions (FAQ)
- What is the address of IMMUNOSCAPE PTE. LTD.?
- Where is IMMUNOSCAPE PTE. LTD.'s headquarter?
- What is IMMUNOSCAPE PTE. LTD.'s contact number?
- What IMMUNOSCAPE PTE. LTD.'s spending power?
- Does IMMUNOSCAPE PTE. LTD. have a presence in the domain it operates in?

